MS SB2023

Caps the total out-of-pocket cost for prescription insulin at $100.00 per 30-day supply for insured individuals, regardless of insulin type or amount needed

Directs the Attorney General to investigate insulin pricing practices in Mississippi, including gathering information from manufacturers, pharmacy benefit managers, and insurers

Requires the Attorney General to submit a public report by November 1, 2022, with findings on pricing practices and recommendations for consumer protections and potential improvements to the Mississippi Consumer Protection Act

Authorizes the Commissioner of Insurance to enforce the insulin cost cap and promulgate rules for implementation

Allows carriers to reduce cost-sharing below the $100.00 cap but prohibits them from requiring more than the capped amount